PI-PLCβ-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes

被引：34

作者：

Follo, M. Y. ^{[1
]}

Finelli, C. ^{[2
]}

Bosi, C. ^{[2
,3
]}

Martinelli, G. ^{[2
]}

Mongiorgi, S. ^{[1
]}

Baccarani, M. ^{[2
]}

Manzoli, L. ^{[1
]}

Blalock, W. L. ^{[1
]}

Martelli, A. M. ^{[1
,4
]}

Cocco, L. ^{[1
]}

机构：

[1] Univ Bologna, Dept Analyt Sci, Cellular Signalling Lab, Bologna, Italy

[2] Univ Bologna, Inst Hematol & Med Oncol, Bologna, Italy

[3] Ospedale Civile Piacenza, Hematol Unit, Piacenza, Italy

[4] IOR, Sez Bologna, Ist Trapianti Organo & Immunocitol CNR, Bologna, Italy

来源：

LEUKEMIA | 2008年 / 22卷 / 01期

关键词：

D O I：

10.1038/sj.leu.2404855

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：198 / 200

页数：4

共 8 条

[1] Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [J].

Cheson, Bruce D. ;

Greenberg, Peter L. ;

Bennett, John M. ;

Lowenberg, Bob ;

Wijermans, Pierre W. ;

Nimer, Stephen D. ;

Pinto, Antonio ;

Beran, Miloslav ;

de Witte, Theo M. ;

Stone, Richard M. ;

Mittelman, Moshe ;

Sanz, Guillermo F. ;

Gore, Steven D. ;

Schiffer, Charles A. ;

Kantarjian, Hagop .

BLOOD, 2006, 108 (02) :419-425

[2] Signal transduction within the nucleus:: Revisiting phosphoinositide inositide-specific phospholipase Cβ1 [J].

Cocco, Lucio ;

Martelli, Alberto M. ;

Fiume, Roberta ;

Faenza, Irene ;

Billi, Anna Maria ;

Manzoli, Francesco Antonio .

ADVANCES IN ENZYME REGULATION, VOL 46, PROCEEDINGS, 2006, 46 :2-11

[3] Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment [J].

Daskalakis, M ;

Nguyen, TT ;

Nguyen, C ;

Guldberg, P ;

Köhler, G ;

Wijermans, P ;

Jones, PA ;

Lübbert, M .

BLOOD, 2002, 100 (08) :2957-2964

[4] The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation [J].

Follo, Matilde Y. ;

Mongiorgi, Sara ;

Bosi, Costanza ;

Cappenini, Alessandra ;

Finelli, Carlo ;

Chiarini, Francesca ;

Papa, Veronica ;

Libra, Massimo ;

Martinelli, Giovanni ;

Cocco, Lucio ;

Martelli, Alberto M. .

CANCER RESEARCH, 2007, 67 (09) :4287-4294

[5]

Follo MY, 2006, INT J MOL MED, V18, P267

[6] Approval summary: Azacitidine for treatment of myelodysplastic syndrome subtypes [J].

Kaminskas, E ;

Farrell, A ;

Abraham, S ;

Baird, A ;

Hsieh, LS ;

Lee, SL ;

Leighton, JK ;

Patel, H ;

Rahman, A ;

Sridhara, R ;

Wang, YC ;

Pazdur, R .

CLINICAL CANCER RESEARCH, 2005, 11 (10) :3604-3608

[7] Inositide-specific phospholipase c β1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia [J].

Lo Vasco, VR ;

Calabrese, G ;

Manzoli, L ;

Palka, G ;

Spadano, A ;

Morizio, E ;

Guanciali-Franchi, P ;

Fantasia, D ;

Cocco, L .

LEUKEMIA, 2004, 18 (06) :1122-1126

[8] Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B [J].

Silverman, LR ;

Demakos, EP ;

Peterson, BL ;

Kornblith, AB ;

Holland, JC ;

Odchimar-Reissig, R ;

Stone, RM ;

Nelson, D ;

Powell, BL ;

DeCastro, CM ;

Ellerton, J ;

Larson, RA ;

Schiffer, CA ;

Holland, JF .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2429-2440

← 1 →